First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
Clinical trial NCT03224702 · COMPLETED
Trial details
- NCT number
- NCT03224702
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-04
- Primary completion
- 2018-08-06
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.